Q4 2022 Aarti Drugs Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Q4 FY22 earnings conference call of Aarti Drugs Limited. This conference call may contain forward-looking statements about the company which are based on the beliefs, opinions and expectations of the company as on date of this call. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict.
(Operator Instructions). Please note that this conference is being recorded, and I now hand the conference over to Mr. Adhish Patil, Chief Financial Officer. Thank you, and over to you, sir.
Good evening, everyone, and thank you for joining us today to discuss our financial results for the quarter and financial year ended March 31, 2022.
Before I take you through the performance highlights, let me remind you that as communicated in the earlier earnings call, the financial performance on a year-on-year basis is not exactly stable, especially in terms of realizations and margins because of elevated API
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
